
    
      Part 1 : Dose-escalation of DS-7423 to determine maximum tolerated dose (MTD) in subjects
      with advanced solid tumors Part 2 : Dose Expansion: The purpose of Part 2 of this clinical
      research study is to confirm the safety and tolerability of the MTD of DS-7423 identified in
      Part 1, and measure the effects of DS-7423 on your cancer. Part 2 will be conducted in
      subjects with advanced colorectal or endometrial cancer.
    
  